Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Jul;102(1):25-27.
doi: 10.1002/cpt.584. Epub 2017 Mar 25.

Pharmacogenetic Implementation Lessons From the "Real World"

D M Roden  1
Affiliations
Comment

Pharmacogenetic Implementation Lessons From the "Real World"

D M Roden. Clin Pharmacol Ther. 2017 Jul.

Abstract

The manuscript "Anticoagulation Endpoints With Clinical Implementation of Warfarin Pharmacogenetic Dosing in a Real- World Setting: A Proposal for a New Pharmacogenetic Dosing Approach" describes process outcomes in an institutional program to use pharmacogenetic testing to optimize warfarin dose in a cohort of 257 patients of diverse ancestries. The strengths and weaknesses of the approach and program are discussed, along with the current and potential future status of warfarin as a model for pharmacogenetic testing.

PubMed Disclaimer

Comment on

References

    1. Furuya H, et al. Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy. Pharmacogenetics. 1995;5:389–392. - PubMed
    1. Rost S, et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature. 2004;427:537–541. - PubMed
    1. Rieder MJ, et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. New England Journal of Medicine. 2005;352:2285–2293. - PubMed
    1. Perera MA, et al. Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study. The Lancet. 2013;382:790–796. - PMC - PubMed
    1. Arwood MJ, et al. Anticoagulation Endpoints with Clinical Implementation of Warfarin Pharmacogenetic Dosing in a Real-World Setting – A Proposal for a New Pharmacogenetic Dosing Approach. Clinical Pharmacology and Therapeutics. 2017 - PMC - PubMed

Publication types